News from the Swiss Cancer Institute

With regular training programs, events and symposia, we promote collaboration and further training of researchers in clinical cancer research.

09. July 2026

Interview: Lorenz Tanner on the SCI Patient Advisory Board and patient-centered research

Universimed spoke with Lorenz Tanner, a member of the SCI Patient Advisory Board, about the importance of patient involvement and the role patients play in clinical cancer research.

22. June 2026

Annual Report 2025 Online: Research, Progress and Transformation

Discover the key research projects, milestones and developments that shaped the Swiss Cancer Institute in 2025.

17. June 2026

Südostschweiz reports on the SAKK 96/12 REDUSE study

An international study led by Prof. Dr. med. Roger von Moos shows that administering denosumab less frequently, while maintaining the same level of efficacy, can reduce the burden on patients.

17. June 2026

ASCO 2026: SAKK 06/19 Shows Promising Results in Bladder Cancer

Results presented at ASCO 2026 demonstrate high response rates with a novel combination of recombinant BCG and perioperative chemoimmunotherapy in muscle-invasive bladder cancer.

09. June 2026

SAKK 96/12 REDUSE: Less Frequent Denosumab Treatment Proven Effective for Patients with Bone Metastases

Results presented at ASCO 2026 show that extending treatment intervals from four to twelve weeks maintains efficacy while reducing side effects, treatment burden, and healthcare costs.

08. June 2026

You can get by with less.

A new study by the Swiss Cancer Institute, led by Dr. Roger von Moos, shows that denosumab—a drug used to treat bone metastases—is just as effective when administered three times less frequently, and actually causes fewer side effects. What does this mean in practice?

04. May 2026

SRF "10 vor 10" - Cancer diagnosis in young adulthood

Young adults are diagnosed with cancer more frequently today than in the past, but there is often a lack of suitable services for 18 to 39-year-olds. "10 to 10" uses the example of a sufferer to show how drastic the diagnosis is and how important sharing and support are.

24. April 2026

SRF report from 24.04.2026: Aspirin as a drug against cancer?

Can a well-known drug such as aspirin also play a role in cancer treatment?

18. March 2026

Recap: Viktor Award Gala 2025

The Swiss Cancer Institute was nominated for the prestigious "Viktor - The Swiss Healthcare Award" in the category "Pioneering achievement in the Swiss healthcare system". The award ceremony took place on 12 March 2025 in the Kursaal Bern and brought together leading personalities and organizations that are actively shaping the healthcare system in Switzerland.

11. March 2026

Swiss Cancer Institute nominated for Viktor Award 2025 - watch the gala live stream

The Swiss Cancer Institute has been nominated for the "Viktor - The Swiss Healthcare Award" in the category "Pioneering achievement in the Swiss healthcare system".